The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.94BCNY
291.71M · vs all stocks (USD)
Updated Nov 18, 2026
Trailing P/E
73.00x
Updated Nov 18, 2026
Revenue (TTM)
2.13BCNY
319.21M · vs all stocks (USD)
Updated Nov 18, 2026
Profit Margin
1.36%
Updated Nov 18, 2026
Beta
0.3630x
vs all stocks
Updated Nov 18, 2026
52-Week Change
-6.65%
vs all stocks
Updated Nov 18, 2026
Market Capitalization
1.94BCNY
291.71M · vs all stocks (USD)
Updated Nov 18, 2026
Enterprise Value
6.19BCNY
928.38M · vs all stocks (USD)
Updated Nov 18, 2026
Trailing P/E
73.00x
Updated Nov 18, 2026
Price to Sales (TTM)
0.9138x
Updated Nov 18, 2026
Enterprise to Revenue
2.91x
Updated Nov 18, 2026
Enterprise to EBITDA
22.03x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 18.03×.Updated Nov 18, 2026
Profit Margin
1.36%
Updated Nov 18, 2026
Operating Margin
-4.88%
Updated Nov 18, 2026
Return on Assets (TTM)
-1.11%
Updated Nov 18, 2026
Revenue (TTM)
2.13BCNY
319.21M · vs all stocks (USD)
Updated Nov 18, 2026
Revenue per Share (TTM)
3.99CNYUpdated Nov 18, 2026
Quarterly Revenue Growth
-40.10%
Updated Nov 18, 2026
Gross Profit (TTM)
83.35MCNY
12.50M · vs all stocks (USD)
Updated Nov 18, 2026
EBITDA (TTM)
343.33MCNY
51.50M · vs all stocks (USD)
Updated Nov 18, 2026
Net Income (TTM)
28.87MCNY
4.33M · vs all stocks (USD)
Updated Nov 18, 2026
Quarterly Earnings Growth (YoY)
-97.82%
Updated Nov 18, 2026
Operating Cash Flow (TTM)
235.24MCNY
35.28M · vs all stocks (USD)
Updated Nov 18, 2026
Levered Free Cash Flow (TTM)
-1.71BCNY
-255.95M · vs all stocks (USD)
Updated Nov 18, 2026
Payout Ratio
0.00%
Updated Nov 18, 2026
Minority Interest (Equity)
-47.07MCNYFY2025 · Dec 31, 2025
Revenue
2.10BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
2.17BCNYFY2025 · Dec 31, 2025
Gross Profit
-61.43MCNYFY2025 · Dec 31, 2025
Operating Income
50.23MCNY
7.53M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-122.68MCNYFY2025 · Dec 31, 2025
Income Tax Expense
3.09MCNYFY2025 · Dec 31, 2025
Net Income
-125.76MCNYFY2025 · Dec 31, 2025
EBIT
-257.33KCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
343.33MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
19.92MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
20.01MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
894.39KCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
122.42MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.1004CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.1004CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
533.07MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
533.07MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-125.76MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
72.24MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
307.86MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-341.26MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
1.10BCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-125.76MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
154.09MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
151.28MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
128.25MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-649.12MCNYFY2025 · Dec 31, 2025
Sale of Investments
81.12MCNYFY2025 · Dec 31, 2025
Other Investing Activity
188.87KCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-567.81MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
3.61BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-3.10BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-126.82MCNYFY2025 · Dec 31, 2025
Other Financing Charges
161.75MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
537.75MCNYFY2025 · Dec 31, 2025
Shares Outstanding
532.83MSharesUpdated Nov 18, 2026
Float Shares
373.04MSharesUpdated Nov 18, 2026
% Held by Insiders
37.75%
vs all stocks
Updated Nov 18, 2026
% Held by Institutions
0.24%
vs all stocks
Updated Nov 18, 2026
Total Cash (MRQ)
447.14MCNY
67.07M · vs all stocks (USD)
Updated Nov 18, 2026
Total Cash per Share (MRQ)
0.8390CNYUpdated Nov 18, 2026
Total Debt (MRQ)
4.83BCNY
724.46M · vs all stocks (USD)
Updated Nov 18, 2026
Current Ratio (MRQ)
0.6570x
Updated Nov 18, 2026
Book Value per Share (MRQ)
-0.1960CNYUpdated Nov 18, 2026
Total Assets
6.44BCNY
965.84M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
2.28BCNYFY2025 · Dec 31, 2025
Total Liabilities
6.36BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
4.16BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
2.44BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
3.92BCNYFY2025 · Dec 31, 2025
Cash
1.13BCNYFY2025 · Dec 31, 2025
Cash Equivalents
10.22MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
1.14BCNYFY2025 · Dec 31, 2025
Accounts Receivable
482.27MCNYFY2025 · Dec 31, 2025
Inventory
359.26MCNYFY2025 · Dec 31, 2025
Accounts Payable
1.15BCNYFY2025 · Dec 31, 2025
Short-term Debt
1.52BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
18.58MCNYFY2025 · Dec 31, 2025
Long-term Debt
1.99BCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
15.89MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
532.83MCNYFY2025 · Dec 31, 2025
Retained Earnings
-2.42BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
84.32MCNY
12.65M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
3.41CNYUpdated Nov 18, 2026
52-Week High
5.51CNYUpdated Nov 18, 2026
52-Week Change
-6.65%
vs all stocks
Updated Nov 18, 2026
Beta
0.3630x
vs all stocks
Updated Nov 18, 2026
50-Day MA
4.21CNYUpdated Nov 18, 2026
200-Day MA
4.30CNYUpdated Nov 18, 2026
Avg 10-Day Volume
11.59MSharesUpdated Nov 18, 2026
Avg 30-Day Volume
25.24MSharesUpdated Nov 18, 2026
Diluted EPS (TTM)
0.0500CNYUpdated Nov 18, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Debt is a large share of its assets, and large against its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score -0.32: distress zoneCritical
Altman Z-Score: -0.32
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Levered free cash flow is -$255.95M, lower than 95% of all stocks globallySignificant